Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody.

Seidel UJ, Schlegel P, Grosse-Hovest L, Hofmann M, Aulwurm S, Pyz E, Schuster FR, Meisel R, Ebinger M, Feuchtinger T, Teltschik HM, Witte KE, Schwarze CP, Rammensee HG, Handgretinger R, Jung G, Lang P.

Mol Ther. 2016 Sep;24(9):1634-43. doi: 10.1038/mt.2016.141. Epub 2016 Jul 6.

2.

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.

Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm S, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G.

Leukemia. 2012 Jun;26(6):1228-37. doi: 10.1038/leu.2011.372. Epub 2012 Jan 6.

PMID:
22289926
3.

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.

Eisele G, Roth P, Hasenbach K, Aulwurm S, Wolpert F, Tabatabai G, Wick W, Weller M.

Neuro Oncol. 2011 Feb;13(2):155-64. doi: 10.1093/neuonc/noq176. Epub 2010 Dec 22.

4.

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.

Miller J, Eisele G, Tabatabai G, Aulwurm S, von Kürthy G, Stitz L, Roth P, Weller M.

J Neurosurg. 2010 Aug;113(2):280-5. doi: 10.3171/2009.11.JNS09901.

PMID:
19961309
5.

Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.

Naumann U, Maass P, Gleske AK, Aulwurm S, Weller M, Eisele G.

Int J Oncol. 2008 Oct;33(4):759-65.

PMID:
18813789
6.

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, Kerr I, Lam A, Webb HK, Kapoun AM, Kizer DE, McEnroe G, Hart B, Axon J, Murphy A, Chakravarty S, Dugar S, Protter AA, Higgins LS, Wick W, Weller M, Wong DH.

Neuro Oncol. 2007 Jul;9(3):259-70. Epub 2007 May 23. Erratum in: Neuro Oncol. 2007 Oct;9(4):465.

7.

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

Scheel B, Aulwurm S, Probst J, Stitz L, Hoerr I, Rammensee HG, Weller M, Pascolo S.

Eur J Immunol. 2006 Oct;36(10):2807-16.

8.

Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.

Roth P, Aulwurm S, Gekel I, Beier D, Sperry RG, Mittelbronn M, Meyermann R, Beaman KD, Weller M, Wischhusen J.

Cancer Res. 2006 Apr 1;66(7):3852-8.

9.
10.

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M.

Cancer Res. 2004 Nov 1;64(21):7954-61.

11.

MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.

Herrlinger U, Aulwurm S, Strik H, Weit S, Naumann U, Weller M.

J Neurooncol. 2004 Jan;66(1-2):147-54.

PMID:
15015780
12.

MICA/NKG2D-mediated immunogene therapy of experimental gliomas.

Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Bühring HJ, Dichgans J, Rammensee HG, Steinle A, Weller M.

Cancer Res. 2003 Dec 15;63(24):8996-9006.

13.

Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M.

Ann Neurol. 2003 Sep;54(3):388-92.

PMID:
12953273
14.

Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters.

Weigert C, Brodbeck K, Brosius FC 3rd, Huber M, Lehmann R, Friess U, Facchin S, Aulwurm S, Häring HU, Schleicher ED, Heilig CW.

Diabetes. 2003 Feb;52(2):527-35.

15.

Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases.

Leitlein J, Aulwurm S, Waltereit R, Naumann U, Wagenknecht B, Garten W, Weller M, Platten M.

J Immunol. 2001 Jun 15;166(12):7238-43.

16.

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M.

Biochem Biophys Res Commun. 2000 Feb 16;268(2):607-11.

PMID:
10679251
17.

Heterogeneity of glycosylphosphatidylinositol-anchored alkaline phosphatase of calf intestine.

Bublitz R, Armesto J, Hoffmann-Blume E, Schulze M, Rhode H, Horn A, Aulwurm S, Hannappel E, Fischer W.

Eur J Biochem. 1993 Oct 1;217(1):199-207.

Supplemental Content

Loading ...
Support Center